BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:21 PM
 | 
May 28, 2009
 |  BC Extra  |  Company News

EMEA accepts regadenoson MAA

EMEA accepted for review an MAA from Gilead Sciences Inc. (NASDAQ:GILD) for regadenoson for use...

Read the full 57 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >